MGEN - Miragen Therapeutics EPS misses by $0.06 beats on revenue March, 11 2020 04:14 PM Miragen Therapeutics Inc. Miragen Therapeutics (NASDAQ:MGEN): Q4 GAAP EPS of -$0.31 misses by $0.06.More news on: Miragen Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...